GenePOC to attend MEDLAB in Dubai from February 4-7 2019
Come visit our booth # Z3 C33 – Discover the power of the PIE and revogene instrument for molecular detection of infectious diseases.
Entries by [email protected]
GenePOC’s Investment in SMRT Panels Validated by Medicare Decision
Read the entire Genomeweb interview to learn more on GenePOC’s vision, future SMRT Panels (Specific, Medically appropriate, Reimbursement appropriate Test) in alignment with the Palmetto decision, and User experience comments on revogene benefits and competitive advantages.
GENEPOC ANNOUNCES HEALTH CANADA APPROVAL OF ITS CDIFF TEST
Read the Press Release here.
GenePOC to attend AMP in San Antonio, USA from 31 of October to 3 of November 2018
Come visit our booth #1629 – Discover the power of the PIE and revogene instrument for molecular detection of infectious diseases.
GenePOC to attend ID Week in San Francisco, USA from 3 to 7 of October 2018
Come visit our booth #1204 – Discover the power of the PIE and revogene instrument for molecular detection of infectious diseases.
GenePOC to attend ASM in Atlanta, USA from 7 to 11 June 2018
GenePOC will participate in the ASM (American Society for Microbiology) from June 7 to 11, in Atlanta, USA. Come visit our booth #1420 – Discover the power of the PIE and revogene instrument for molecular detection of infectious diseases.
Practical Patient Care Interview – Infection test for expectant mother
Practical Patient Care talks to Dr Mayra Bermudez Martinez, an obstetrician in the Klinik für Gynäkologie und Geburtshilfe at the Hochst Klinikum in Frankfurt, about the importance of timely screening for Group B Streptococcus in infants. Read the entire article here.
GenePOC to attend 28th ECCMID in Madrid, Spain from 21 to 24 April
GenePOC will participate in the 28th ECCMID (European Congress of Clinical Microbiology and Infectious Diseases) from April 21 to 24, in Madrid, Spain. Come visit our booth #40 – Discover the power of the PIE and revogene instrument for molecular detection of infectious diseases. Don’t miss our symposium on Monday 23rd – Hall J – […]
GenePOC Signs Assay Development Contract for Diagnosis of Respiratory Infections with Novacyt !
Under the terms of the services agreement, Primerdesign will develop a triplex molecular diagnostic assay to identify influenza A, influenza B and respiratory syncytial virus A and B (RSV A and B) which will subsequently be run on GenePOC’s revogene™ instrument. Full article : here
2017 IDSA Guidelines State the Role of PCR Testing for C. difficile Diagnosis
Clostridium difficile infection (CDI) is the main cause of infectious antibiotic-associated diarrhea with approximately 500,000 infections and $4.8 billion in excess healthcare cost per year in the US1. While diagnosis of C. difficile still remains controversial worldwide, the new IDSA guidelines reaffirm that PCR is the most sensitive method for toxigenic C. difficile detection. Find here […]